IBDEI0YD ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15507,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,15507,1,2,0)
 ;;=2^96167
 ;;^UTILITY(U,$J,358.3,15507,1,3,0)
 ;;=3^Hlth/Behav Intvn,Fam & Pt,1st 30 min
 ;;^UTILITY(U,$J,358.3,15508,0)
 ;;=96168^^59^748^7^^^^1
 ;;^UTILITY(U,$J,358.3,15508,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,15508,1,2,0)
 ;;=2^96168
 ;;^UTILITY(U,$J,358.3,15508,1,3,0)
 ;;=3^Hlth/Behav Intvn,Fam & Pt,Ea Addl 15 min
 ;;^UTILITY(U,$J,358.3,15509,0)
 ;;=96170^^59^748^8^^^^1
 ;;^UTILITY(U,$J,358.3,15509,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,15509,1,2,0)
 ;;=2^96170
 ;;^UTILITY(U,$J,358.3,15509,1,3,0)
 ;;=3^Hlth/Behav Intvn,Fam w/o Pt,1st 30 min
 ;;^UTILITY(U,$J,358.3,15510,0)
 ;;=96171^^59^748^9^^^^1
 ;;^UTILITY(U,$J,358.3,15510,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,15510,1,2,0)
 ;;=2^96171
 ;;^UTILITY(U,$J,358.3,15510,1,3,0)
 ;;=3^Hlth/Behav Intvn,Fam w/o Pt,Ea Addl 15 min
 ;;^UTILITY(U,$J,358.3,15511,0)
 ;;=36416^^59^749^1^^^^1
 ;;^UTILITY(U,$J,358.3,15511,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,15511,1,2,0)
 ;;=2^36416
 ;;^UTILITY(U,$J,358.3,15511,1,3,0)
 ;;=3^Capillary Blood Draw
 ;;^UTILITY(U,$J,358.3,15512,0)
 ;;=99606^^59^749^2^^^^1
 ;;^UTILITY(U,$J,358.3,15512,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,15512,1,2,0)
 ;;=2^99606
 ;;^UTILITY(U,$J,358.3,15512,1,3,0)
 ;;=3^MTMS by PHARM,EST,15 min
 ;;^UTILITY(U,$J,358.3,15513,0)
 ;;=99606^^59^749^3^^^^1
 ;;^UTILITY(U,$J,358.3,15513,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,15513,1,2,0)
 ;;=2^99606
 ;;^UTILITY(U,$J,358.3,15513,1,3,0)
 ;;=3^MTMS by PHARM,NP,15 min
 ;;^UTILITY(U,$J,358.3,15514,0)
 ;;=99607^^59^749^4^^^^1
 ;;^UTILITY(U,$J,358.3,15514,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,15514,1,2,0)
 ;;=2^99607
 ;;^UTILITY(U,$J,358.3,15514,1,3,0)
 ;;=3^MTMS by PHARM,Addl 15 min
 ;;^UTILITY(U,$J,358.3,15515,0)
 ;;=90732^^59^750^28^^^^1
 ;;^UTILITY(U,$J,358.3,15515,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,15515,1,2,0)
 ;;=2^90732
 ;;^UTILITY(U,$J,358.3,15515,1,3,0)
 ;;=3^PNEUMOVAX 23 (PNEUMOCOCCAL VACCINE)
 ;;^UTILITY(U,$J,358.3,15516,0)
 ;;=90585^^59^750^1^^^^1
 ;;^UTILITY(U,$J,358.3,15516,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,15516,1,2,0)
 ;;=2^90585
 ;;^UTILITY(U,$J,358.3,15516,1,3,0)
 ;;=3^BCG VACCINE, PERCUT
 ;;^UTILITY(U,$J,358.3,15517,0)
 ;;=90632^^59^750^16^^^^1
 ;;^UTILITY(U,$J,358.3,15517,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,15517,1,2,0)
 ;;=2^90632
 ;;^UTILITY(U,$J,358.3,15517,1,3,0)
 ;;=3^HEP A VACCINE, ADULT IM
 ;;^UTILITY(U,$J,358.3,15518,0)
 ;;=90636^^59^750^17^^^^1
 ;;^UTILITY(U,$J,358.3,15518,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,15518,1,2,0)
 ;;=2^90636
 ;;^UTILITY(U,$J,358.3,15518,1,3,0)
 ;;=3^HEP A/HEP B VACC, ADULT IM
 ;;^UTILITY(U,$J,358.3,15519,0)
 ;;=90647^^59^750^20^^^^1
 ;;^UTILITY(U,$J,358.3,15519,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,15519,1,2,0)
 ;;=2^90647
 ;;^UTILITY(U,$J,358.3,15519,1,3,0)
 ;;=3^HIB VACCINE, PRP-OMP, IM
 ;;^UTILITY(U,$J,358.3,15520,0)
 ;;=90648^^59^750^21^^^^1
 ;;^UTILITY(U,$J,358.3,15520,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,15520,1,2,0)
 ;;=2^90648
 ;;^UTILITY(U,$J,358.3,15520,1,3,0)
 ;;=3^HIB VACCINE, PRP-T, IM
 ;;^UTILITY(U,$J,358.3,15521,0)
 ;;=90649^^59^750^15^^^^1
 ;;^UTILITY(U,$J,358.3,15521,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,15521,1,2,0)
 ;;=2^90649
 ;;^UTILITY(U,$J,358.3,15521,1,3,0)
 ;;=3^H PAPILLOMA VACC 3 DOSE IM
